|
Originally published In Press as doi:10.1074/jbc.M104466200 on July 2, 2001
J. Biol. Chem., Vol. 276, Issue 36, 33681-33688, September 7, 2001
Electron Spin Resonance and Fluorescence Studies of the
Bound-state Conformation of a Model Protein Substrate to the Chaperone
SecB*
Vikram G.
Panse §,
K.
Beena ,
Reinhard
Philipp¶,
Wolfgang E.
Trommer¶,
Pia D.
Vogel¶, and
Raghavan
Varadarajan **
From the Molecular Biophysics Unit, Indian Institute
of Science, Bangalore 560 012, India, Chemical Biology Unit,
Jawaharlal Center for Advanced Scientific Research, Jakkur P. O.,
Bangalore 560 004, India, and ¶ Fachbereich Chemie/Abteilung
Biochemie der Universitat Kaiserslautern, Erwin Schrodinger Str.,
67663 Kaiserslautern, Germany
Received for publication, May 16, 2001, and in revised form, June 26, 2001
 |
ABSTRACT |
SecB is a homotetrameric, cytosolic chaperone
that forms part of the protein translocation machinery in
Escherichia coli. We have investigated the bound-state
conformation of a model protein substrate of SecB, bovine pancreatic
trypsin inhibitor (BPTI) as well as the conformation of SecB itself by
using proximity relationships based on site-directed spin-labeling and
pyrene fluorescence methods. BPTI is a 58-residue protein and contains three disulfide groups between residues 5 and 55, 14 and 38, as well as
30 and 51. Mutants of BPTI that contained only a single disulfide were
reduced, and the free cysteines were labeled with either thiol-specific
spin labels or pyrene maleimide. The relative proximity of the labeled
residues was studied using either electron spin resonance spectroscopy
or fluorescence spectroscopy. The data suggest that SecB binds a
collapsed coil of reduced unfolded BPTI, which then undergoes a
structural rearrangement to a more extended state upon binding to SecB.
Binding occurs at multiple sites on the substrate, and the binding site
on each SecB monomer accommodates less than 21 substrate residues. In
addition, we have labeled four solvent-accessible cysteine residues in
the SecB tetramer and have investigated their relative spatial
arrangement in the presence and absence of the substrate protein. The
electron spin resonance data suggest that these cysteine residues are
in close proximity (15 Å) when no substrate protein is bound but move
away to a distance of greater than 20 Å when SecB binds substrate. This is the first direct evidence of a conformational change in SecB
upon binding of a substrate protein.
 |
INTRODUCTION |
Molecular chaperones are a class of proteins that prevent
aggregation of newly synthesized or previously denatured polypeptides and proteins and mediate their folding into the native state (1). The
common property shared by most molecular chaperones is the ability to
recognize structural elements exposed in unfolded or partially
denatured states such as hydrophobic surfaces. They do not bind the
native state of proteins and are capable of interacting with a variety
of different polypeptide chains, often without apparent sequence
preferences (1, 2). SecB is a tetrameric chaperone in Escherichia
coli that is involved in the translocation of polypeptide chains
into the periplasmic space of the cell (3). In vivo, SecB
binds to a subset of precursor proteins and maintains them in an
unfolded, translocation-competent state, whereas in vitro it
interacts with a variety of proteins in the non-native state (4-7).
The nature of the translocation-competent state of substrate proteins
is unknown, although it is believed to be a flexible molten globule
state (8). For some proteins the translocation-competent state contains
significant secondary and tertiary structure (4). Studies on the model
protein substrate, barstar, revealed that SecB does not bind the
folded or unfolded state but traps a near native-like molten globule
state (6). SecB has also been shown to bind partially folded states of
lactalbumin (9).
Bovine pancreatic trypsin inhibitor,
BPTI,1 has been extensively
used as a model protein for folding studies. It consists of 58 residues
and is stabilized by three disulfide bonds between the amino acids 5 and 55, 14 and 38, as well as 30 and 51. The stability of BPTI is
directly linked to the formation of these three disulfide bonds, and
reduction of the disulfides results in unfolding of the protein. Both
non-native and native disulfide intermediates formed during the folding
of BPTI have been well characterized (10-12). The structures of single
disulfide intermediates and of unfolded BPTI have also been
characterized (10-13). Various biophysical measurements suggest that
reduced BPTI can exist in a compact conformation that is almost devoid
of secondary structure elements (14- 20). BPTI is a convenient model
substrate to study interactions between SecB and substrate proteins.
The kinetics and thermodynamics of the interaction of SecB with
reduced, unfolded BPTI has previously been characterized (10). It was
shown that SecB binds to reduced, unfolded BPTI with a stoichiometry of
one BPTI molecule per SecB monomer, a Kd in the
nanomolar range, and an on-rate that is close to diffusion controlled rates.
ESR spectroscopy using site-specific spin labeling of unique cysteine
residues has been used successfully in recent years to study protein
structures and structural changes in a variety of different proteins
and enzymes (21). The approach has been further extended to measure
distances between two site-specifically placed spin-labels by
calibrating spectral components to the distances derived from well
known helical structures of peptides (22). A similar approach has been
employed recently to determine the proximity of helices and their
relative movement upon photoactivation in bacteriorhodopsin (23,
24).
A second biophysical technique that has been used to study proximity of
residues in proteins is pyrene excimer fluorescence (25). Pyrene
excimer fluorescence has been extensively used to determine proximity
of residues in helices of the membrane protein lac permease (26, 27).
Determination of inter-residue distances provides a strategy to deduce
the proximity of selected secondary structural elements and therefore
allows insight into the global structure or structural changes of a
protein at the level of the backbone fold (21). In the present work, we
have used unfolded BPTI as a model substrate to gain insights into the
bound state conformation of polypeptides interacting with the chaperone
SecB. We have investigated the binding of SecB to several BPTI mutants
that were labeled at two Cys residues with either pyrenes or spin
labels. Single disulfide mutants of BPTI in which alanines had been
substituted for the other cysteine residues were used. The mutant
proteins were labeled in the reduced state with either the spin labels
or pyrene maleimides, and the proximity of the labeled residues was
studied using fluorescence methods and ESR spectroscopy.
 |
MATERIALS AND METHODS |
Protein Purification--
The SecB expression plasmid pJW25 in
strain BL21 (DE3) was obtained from B. de Kruijff, Utrecht University.
SecB purification was done as reported previously (6). The purified
protein was estimated to be 99% pure by SDS-polyacrylamide gel
electrophoresis as detected by silver staining (28) and analytical gel
filtration high performance liquid chromatography. The extinction
coefficient at 280 nm was taken to be 11,900 M 1 cm 1 for monomeric SecB (29).
All the SecB concentrations reported here refer to monomers of SecB
unless otherwise stated. Purification of the single disulfide BPTI
mutants was performed as described (10, 12, 20, 30).
Pyrene- and Spin-labeling of SecB and
BPTI--
4-(3-Iodo-2-oxypropylidene-1-)-2,2,3,5,5-pentamethyl-imidazolidine-1-oxyl
(IOPI) was prepared as described in Volodarsky (31).1 mg of the single
disulfide mutants of BPTI were reduced in 200 µl of 6 M
guanidine hydrochloride in Tris-HCl, pH 8.8, containing 10 mM dithiothreitol. The reaction mixture was desalted on a
PD-10 column (Amersham Pharmacia Biotech) and lyophilized. The reduced proteins were dissolved in 200 µl of 6 M guanidine
hydrochloride in potassium phosphate buffer, pH 7.4, and 50 µl of a
20 mM solution of IOPI in
N,N-dimethylformamide was added. The mixture was
then incubated for 1 h in the dark at 25 °C, desalted on a
PD-10 column, and lyophilized. For pyrene labeling, reduced protein was
dissolved in 200 µl of 6 M guanidine hydrochloride in
potassium phosphate buffer, pH 7.4, as described above, and 50 µl of
a 20 mM solution of pyrene maleimide in
N,N-dimethylformamide was added. The reaction mixture was again incubated for 1 h in the dark at room
temperature, desalted on a PD-10 column, and lyophilized. The extent of
labeling was assayed according to Creighton (32) and found to be 1.9 Cys residues/BPTI molecule. To label SecB with pyrene maleimide or IOPI-spin label, a similar procedure was carried out as described above except that guanidine hydrochloride was excluded from the reaction mixture to avoid denaturation of the protein.
The oligomeric state of the protein after cysteine modification was
analyzed by subjecting both labeled and unlabeled SecB to gel
filtration on a Superdex 75 HR 10/30 (Amersham Pharmacia Biotech) gel
filtration column. The column was equilibrated with 50 mM
sodium phosphate buffer, pH 7.4, containing 150 mM NaCl.
The extent of spin- or pyrene-labeling was assayed by determining the
amount of residual, unreacted SH groups as described previously. Both
under denaturing and under non-denaturing conditions, three unreacted
sulfhydryl groups were found per monomer, suggesting that only one of
the four cysteines per monomer was modified by our reagents.
Similar results were described earlier (33).
In the case of the pyrene-labeled SecB, the extent of labeling was also
analyzed by mass analysis. Positive ESI-MS of the unlabeled and the
pyrene-labeled SecB was recorded on a Hewlett Packard Series 1100 mass
selective detector mass spectrometer to confirm the presence of
a single pyrene chromophore per SecB monomer. Detection of the uniquely
labeled cysteine was done by carrying out CNBr cleavage on the tryptic
digest of the unlabeled and the pyrene-labeled SecB as described (34).
MALDI of the peptide mixtures was performed on a Kompact SEQ mass
spectrometer (Kratos Analytical). 10 mg/ml -cyano-4-hydroxy-cinnamic
acid in acetonitrile/methanol/water, 5:3:2, was used as a matrix
solution, and the spectra were obtained in the linear mode.
ESR Measurements--
The ESR measurements were carried out
using a Bruker ESP 300 E spectrometer operating in the X-band mode. A
dielectric cavity TE011 (ER 4118) was used for all
experiments. 20-µl aliquots of the spin-labeled proteins in 100 mM potassium phosphate buffer, pH 7.4, were prepared in
sealed quartz capillaries. Spectra of the samples at room temperature
(298 K) were obtained by averaging 3-5 scans at a scan width of 120 Gauss. The microwave power was set to be 2 mW, and the modulation
amplitude was optimized to the line-width of the individual spectra.
ESR spectra in the frozen state (183 K) were recorded at a microwave
power of 0.05 mW.
Fluorescence Measurements--
All fluorescence emission
experiments were carried out using a Jasco FP 777 fluorimeter. The
fluorescence measurements were carried out in a 1-cm quartz cuvette at
25 °C with an excitation wavelength of 344 nm. To obtain the
excitation spectra, the excitation wavelength was varied from 320 to
360 nm, and the fluorescence was monitored at 377 nm and 450 nm for
monomer and excimer fluorescence, respectively. A slit width of 1.5 nm
was used for measuring both excitation and emission. The binding
affinity of the different pyrene-labeled BPTI mutants for SecB was
carried out as follows. 25 nM labeled BPTI in 100 mM potassium phosphate buffer was taken in the cuvette held
at 25 °C. Increasing amounts of SecB from 10 to 500 nM
were added, and the increase in fluorescence intensity at 400 nm was
recorded. The data were analyzed as described (5, 9) to obtain the
dissociation constant.
Homology Modeling of E. coli SecB Structure--
Comparative
protein structure modeling program MODELLER (35) was used for the model
building of the E. coli SecB structure. The program was
downloaded from the MODELLER homepage on the Internet. Multiple
sequence alignment of eight bacterial SecB proteins using ClustalW
shows that the E. coli SecB has 60% sequence identity with
the Hemophilus influenzae SecB. Three of the four cysteines, corresponding to the positions 76, 97, and 102, are conserved, whereas
leucine is present at the position of the H. influenzae SecB
that corresponds to Cys-113 of the E. coli SecB. The crystal structure of the H. influenzae SecB (36) was then used as
the template structure.
The crystal structure reveals that SecB is organized as a dimer of
dimers. The solvent accessibility of the cysteine residues was
determined using the programs DEPTH (37) and ACCESS (38) and the
coordinates of the crystal structure of SecB. The results from these
two programs indicated that the cysteines in each monomer are
accessible to slightly different extents. Hence, we modeled the
E. coli SecB for the four monomers independently, taking the monomers of the H. influenzae SecB as templates. The four
modeled monomers were combined to give the modeled structure of the
tetrameric protein. The accessibility of the cysteines was then
determined by using the programs DEPTH and ACCESS on the modeled
structure. The distances between the S of the cysteines was
determined using RASMOL. A bound IOPI spin-label at position 97 was
also modeled on the modeled structure of E. coli SecB
tetramer using the programs Quanta 97 and CharmM 2.3 (Molecular
Simulations) for modeling and energy minimization. The nitroxide group
of the IOPI spin-label is at a distance of about 7.5 Å from the
position of the corresponding cysteine residue. The modeling was done
to determine the distance between the nitroxide radicals in the
IOPI-labeled cysteines.
 |
RESULTS |
Reduced, unfolded BPTI has been previously shown to bind to SecB
(5, 7). However, little is known about the regions of the substrate
that are involved in binding, the conformation of bound substrate, and
whether substrate binding is accompanied by a change in SecB
conformation. We have used two different approaches to obtain this
information. In a first set of experiments, we have incorporated into
unfolded BPTI a pair of either spin labels or fluorescent labels at
various positions along the primary sequence to investigate the
proximity of the labels relative to each other in the free as well as
the SecB-bound state. In a second approach, the four solvent-accessible
cysteine residues on SecB were labeled to study potential structural
changes of the chaperone upon binding the permanently denatured
(BPTI)all Ala.
Pyrene Fluorescence of BPTI Mutants--
The single disulfide
mutants of BPTI 5-55, 30-51, and 14-38 were labeled with pyrene
maleimide, and the labeling efficiency was checked as described under
"Materials and Methods." The fluorescence emission spectrum of
pyrene (excited at 345 nm) is composed of two bands, a structured band
with peaks near 385 and 405 nm, which is referred to as the monomer
peak, and an unstructured broad peak near 470 nm that is observed when
two pyrenyl groups are close to each other at a distance of ~3.5 Å (excimer band). Upon binding of the labeled mutants of BPTI to SecB, an
increase in fluorescence intensity is observed, indicating that the
pyrene probes are in a hydrophobic environment upon binding to the
chaperone as described previously (39). Fig.
1 shows the pyrene emission of labeled
BPTI mutants in the presence (dotted lines) and absence (solid lines) of SecB. The addition of SecB to labeled BPTI
results in changes in fluorescence intensities of both monomer and
excimer peaks. These changes are due in part to decreased quenching of pyrene fluorescence by solvent in the SecB-bound state. Hence, to
analyze intensities of the excimer peak in the presence of SecB, the
spectra were normalized to have identical intensity at 377 nm both in
the presence and absence of SecB. Pyrene modifications at the amino
acid positions 5 and 55 or 30 and 51 (Fig. 1, A and B, solid lines) show relatively weak excimer
fluorescence, indicating that in both sets of mutants, the chromophores
are at distances greater than 3.5 Å. Stronger excimer fluorescence is
observed when the labels were in positions 14 and 38 (Fig. 1,
C, solid line). Upon binding of the labeled BPTI
to SecB, the weak excimer fluorescence of the mutants with the labeled
residues (5-55)Py and (30-51)Py decreased
even further (Fig. 1, A and B, dotted lines). Also in the case of labeled residues
(14-38)Py (Fig. 1C, dotted line), a
large decrease in excimer fluorescence is observed upon the addition of
SecB, although some excimer fluorescence remained.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Normalized fluorescence spectra of
pyrene-labeled BPTI mutants at 25 °C, pH
7.4. The fluorescence spectra were normalized to have an identical
intensity at 377 nm. A, 1 µM
(5-55)Py alone (solid line) and in complex with
10 µM SecB (dotted line). B, 1 µM (30-51)Py alone (solid line)
and in complex with 10 µM SecB(dotted line).
C, 1 µM (14-38)Py alone
(solid line) and in complex with 10 µM SecB
(dotted line).
|
|
Determination of the Site of Attachment of the Thiol Label to
Native SecB--
We have labeled the four solvent-accessible cysteine
residues in SecB (one Cys per monomer) using pyrene maleimide (33). Modification of the cysteine residue in SecB by
5,5'-dithiobis(nitrobenzoic acid) is reported to cause irreversible
dissociation of the tetramer to dimer (40). Hence, both pyrene-labeled
and the unlabeled SecB were analyzed by gel chromatography to check for
the oligomeric state of the protein after labeling. Pyrene-labeled SecB
elutes at the same position as the unlabeled SecB. This indicates that both labeled and unlabeled proteins exist primarily as tetrameric species in solution and that no dimer is present (Fig.
2). The shoulder in the gel filtration
profile of the pyrene-labeled SecB, appearing in the void volume of the
column, could be indicative of the presence of a small fraction of
aggregate. However no aggregated species is present for the
spin-labeled protein.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Size exclusion chromatography of SecB.
Unlabeled and labeled SecB were subjected to fast protein liquid
chromatography on a Superdex 75 HR 10/30 gel filtration column as
described under "Materials and Methods." The dashed
line, open circles, and solid line represent
pyrene-labeled SecB, spin-labeled SecB, and unlabeled SecB,
respectively. The shoulder, present for pyrene-labeled protein at the
void volume of the column, probably results from the presence of some
aggregated species.
|
|
5,5'-Dithiobis(nitrobenzoic acid) labeling as well as the ESI-MS of the
pyrene-labeled SecB confirmed pyrene labeling of a single cysteine per
SecB monomer (Fig. 3A).
Although there are four cysteines in SecB monomer at the positions 76, 97, 102, and 113 that can be selectively modified by thiol-labeling
reagents, MALDI of the proteolysed mixture of the pyrene-labeled SecB
showed that only the peptide fragment 95-111 contains a cysteine with a single pyrene (Fig. 3, B and C). Thus either
cysteine 97 or cysteine 102 is likely to be the site of labeling. Since
the two cysteines are very close to each other in the primary sequence, it was not possible to experimentally determine which of the two was
the actual site of labeling using this technique. We therefore modeled
the E. coli SecB as described under "Materials and
Methods." Table I summarizes the
relative accessibility in both the crystal structure and the modeled
structure. The table shows that with the exception of chain A, residue
97 is the most accessible in both the crystal and model structures. For
chain A, Cys-102 is most exposed in the model, and Leu-122 (equivalent
to Cys-113 in E. coli SecB) is most exposed in the crystal
structure. It is possible that Cys-97 is labeled in three chains, and
in chain A either no Cys is labeled or either Cys-102 or Cys-113 is
labeled. Previous 5,5'-dithiobis(nitrobenzoic acid) labeling studies
showed that four Cys residues are labeled per tetramer (33). Mass
spectrometric studies did not show any evidence for labeling of
Cys-113. Taken together the data suggest that either Cys-97 is labeled
in all chains or that Cys-102 is labeled in chain A, and Cys-97 is
labeled in the remaining chains. The pyrene-labeled SecB was further
characterized by fluorescence spectroscopy. No excimer formation was
observed (data not shown). This indicates that the pyrenes are held
rigidly at a distance of more than 3.5 Å and are probably part of a
secondary structural element of the protein. The inter-cysteine
distances for the two cysteine residues, 97 and 102, that are the most
probable sites of labeling, are indeed greater than 3.5 Å in the
structure (Table IB). The addition of the unfolded
(BPTI)all Ala mutant leads to an increase in fluorescence
of the labeled pyrenes of SecB, indicating a change in the environment
upon binding of the substrate molecules. This is suggestive of a
conformational transition of the chaperone upon binding of the
substrate protein. Alternatively the substrate binding may occur close
to the site of the pyrene label on SecB. ESR studies described below,
however, support the first possibility.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
A, ESI-MS of the SecB monomer.
Positive ion mass spectrum of SecB in acetonitrile, pH 3.0. In
panel I, peak A denotes the acetylated form of
SecB (17,189 + 5D). In panel II, peak A
and peak B denote the single pyrene-labeled acetylated
(17,486 + 4D) and nonacetylated (17,442 + 6D) form of SecB
respectively. B, MALDI-time of flight mass spectra of SecB
after Trypsin/CNBr treatment. The asterisks indicate the
peak corresponding to the peptide fragment 95-111. The front and back
spectra are for the pyrene-labeled and the unlabeled SecB,
respectively. C, peptide fragments from trypsin digestion of
SecB. The arrows indicate the trypsin cleavage sites. The
single cysteine that can be covalently labeled in native SecB lies
within the stretch of residues from 95-111 that is
underlined and in bold. This was determined by
subjecting the tryptic digest of the labeled protein to CNBr cleavage
and the analysis by MALDI-time of flight as described in panel
B above.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
A. Accessibility (%) of the cysteine residues in the modeled E. coli SecB and in the crystal structure of H.
influenzae SecB. Homologous positions in the two structures are
in the same column of the table.
|
|
ESR Studies of Site-specifically Spin-labeled BPTI
Mutants--
The ESR spectra of the different spin-labeled mutants of
BPTI show the typical line-broadening that occurs upon covalent binding of the radicals to a protein. As a typical example, the spectra of the
labeled mutant (14-38)SL are shown in Fig.
4. The fact that the line broadening is
mainly observed as reduced signal amplitude of the high field signal
(Fig. 4A) indicates that the bound radicals still have
rather high mobility. This is consistent with the spin-labeled BPTI
being in an unfolded state. Upon the addition of SecB, additional
signals with a 2Azz value of 63 G are apparent in the low
and high field region of the ESR spectra (Fig. 4B,
1, 1'), indicating that binding of the labeled
BPTI to the chaperone SecB has taken place. The relative area of peaks 1 and 1' corresponds to ~50% of the total radicals, whereas the sharp signals of the highly mobile spin labels have decreased by about
50% as compared with Fig. 4A under normalized
conditions. Such observations are indicative of restricted motional
freedom of one of the two spin labels covalently bound to BPTI or by
binding of ~50% of the labeled substrate protein. Similar spectra
were observed by the authors in the case of lactate dehydrogenase (41), where the bound radical component was hardly visible at all but still
accounted for 30% of the total spin-labeled substrate. The binding
constant of unfolded BPTI for SecB under the conditions of the ESR
experiments was determined to be 10 nM using fluorescence spectroscopy, an observation that is in agreement with findings described earlier (5, 39). Therefore, we assume that the sharp signals
must originate from SecB-bound BPTI since there should be virtually no
free BPTI present under the conditions used in the experiment (30 µM labeled BPTI in the presence of 300 µM
SecB). Similar observations, e.g. decrease by 50% of the mobile component while an immobile spectral component representing about 50% of the total radical occurs, were made also for the binding
of the BPTI mutants (5-55)SL and (30-51)SL
(data not shown). The data suggest that SecB consistently interacts
with only one of the two radicals within the mutant BPTI peptide
chains.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 4.
ESR spectra of spin labeled
(14-38)sl mutant alone and in complex with SecB.
A, 30 µM of (14-38)SL alone at
298 K, pH 7.4. B, 30 µM of
(14-38)SL in complex with 300 µM SecB at 298 K, pH 7.4. The arrows indicate the signal of the mobile
fraction of the radical moiety that has decreased by about 50% upon
binding to SecB. The absolute intensities in A and
B are on an identical scale. C, ESR spectra of
A recorded at 183 K; D, ESR spectra of
B recorded at 183 K.
|
|
It was previously described that the extent of magnetic dipolar
interaction between two spin-labeled cysteine side chains can be used
to estimate the distance between bound radicals (22). To evaluate the
line broadening due to static dipolar interactions, quantitative
analysis of the inter-spin distance can be carried out in the absence
of motion by acquiring the spectra in the frozen state (183 K). An
estimation of the extent of broadening due to dipolar interaction is
obtained from the line height ratio
d1/d (Fig. 4, C and
D), which is in direct correlation to the average distance
of the radicals from each other. In the absence of interaction (when a
distance greater than 20 Å separates the radicals), a value of
d1/d of less than 0.4 is expected
(22). Table II summarizes the
d1/d values of the three doubly
labeled BPTI mutants in the presence and absence of SecB. The
d1/d ratio never reaches a value that
would suggest dipolar interaction in the unbound state of BPTI. This
indicates that the radicals bound to BPTI are further than 20 Å apart
and that the conformation of the substrate bound to SecB is an extended
one.
ESR Studies on the Chaperone SecB--
SecB has four
solvent-accessible cysteines (one per monomer), as assayed by the thiol
reactive probes 5,5'-dithiobis(nitrobenzoic acid) and pyrene maleimide
(33). The labeling, proteolysis, mass spectrometry, and modeling
studies described above suggest cysteine 97 as the residue that is
labeled. To obtain further insight into the possible conformational
changes upon substrate binding, we have labeled the accessible
cysteines using IOPI spin label. The ESR spectra of the spin-labeled
chaperone indicate that the chaperone-bound radicals retain too much
rotational freedom to determine the amount of dipolar spin-coupling
from room temperature measurements (data not shown). Hence, low
temperature spectra were acquired where the radicals were in a frozen
state (Fig. 5A). The
d1/d value of the spectrum was
determined to be 0.45, indicative of a relative, average distance of
the radicals of about 20 Å or less (22). Line shape simulations using
a program designed by Steinhoff et al. (42) resulted in a
good fit of the spectrum in Fig. 5A (see inset)
at an inter-spin distance of 14 ± 4.5 Å between the radicals.
The addition of the unfolded substrate (BPTI)all Ala led
to a drastic decrease in the d1/d
ratio to 0.36, whereas the 2Azz value remained the same, indicating that the spin-labeled cysteines have moved apart from each
other upon binding of the substrate protein (Fig. 5B). The spectra could be fitted well when the inter-spin distance of the radicals was set to 30 Å (where dipolar interactions cannot be observed) in the program (Fig. 5B, inset).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
ESR spectra of spin labeled SecB in the
presence and absence of (BPTI)all Ala at 183 K. A, 20 µM of spin-labeled SecB alone;
B, 20 µM of spin-labeled SecB in complex with
100 µM of (BPTI)all Ala. The
insets represent the computer-simulated ESR data using the
program Dipfit (42).
|
|
As described under "Materials and Methods," we used the model of
the E. coli Sec B that we had obtained by aligning the
E. coli sequence to the known crystal structure (36) and
modeled a bound IOPI spin-label at position 97 of the E. coli sequence. The distance of between two NO radicals was
determined to be ~18 Å, in excellent agreement with the value of
14 ± 4.5 Å determined from the line shape simulations described
above. This is also consistent with the inter-cysteine distances
indicated in Table IB and the length of the IOPI group, which spans
about 7.5 Å from the nitroxide label to the site of attachment at the
S atom of Cys.
 |
DISCUSSION |
Both in prokaryotes and eukaryotes, proteins have to cross
membranes either during or after their biosynthesis to reach their final destination. It is assumed that folded proteins are not translocation-competent. It has been suggested that during
translocation proteins may be in a molten globule-like state (8).
However the actual physical state of such proteins has not been well
characterized. A variety of cellular chaperones that are involved in
the protein translocation machinery of the cell have been found to play
important roles in maintaining the nascent polypeptide chains in a
non-native state. It is assumed that chaperones can bind to regions of
the unfolded polypeptide chains, which are buried in the native state of the proteins (1). Thus, binding between chaperones and target substrate proteins is believed to be largely mediated by hydrophobic interactions, which is also a way of preventing nonspecific protein aggregation in the cell. The main function of the chaperone SecB is to
maintain target precursor proteins in a translocation-competent state.
We have investigated the free and the bound state conformations of both
SecB and the model substrate protein, BPTI, by using either pyrene dyes
or spin labels to study the spatial arrangement of different residues
within both proteins. The studies were interpreted in light of the
recently determined crystal structure of SecB from H. influenzae.
Proximity Relationships of Cysteines in Unfolded and SecB-bound
BPTI--
In aqueous solutions, pyrene probes that are covalently
attached to a protein will equilibrate between stacked and unstacked configurations in the ground state if permitted by the local
conformation of the protein. If flexible regions separate the pyrene
moieties, the stacked configuration should dominate due to energetic
reasons. Changes in the conformation of the protein near the pyrene
probes will influence the equilibrium between stacked and unstacked
pyrenes and will therefore change the ability to exhibit excimer
fluorescence. Three different single-disulfide mutants of BPTI were
used in the present work. Reduction of the disulfide bond results in
two free cysteine thiol groups that can be chemically modified using SH-specific reagents such as maleimide or the iodo-oxopropylidene spin-label, IOPI. Reduction of the disulfide bond also results in
denatured BPTI that functions as a substrate protein for SecB. The two
BPTI mutants, with cysteines labeled at 5-55 and at 30-51 respectively, exhibit only weak excimer fluorescence (Fig. 1, panels A and B, solid lines). Strong
excimer fluorescence is observed for a single disulfide mutant with
pyrenes at positions 14-38, Fig. 1 (panel C, solid
line). Excimer formation at the positions 14-38 may be enhanced
by the presence of tertiary interactions within this region. These
interactions are prevalent even in the unfolded state of the protein,
as was indicated by two-dimensional 1H NMR spectra of
reduced BPTI and fluorescence energy transfer data on the collapsed
molten coil state of BPTI (16, 19, 20). The data indicate that the two
cysteine residues at positions 14 and 38 are in close proximity even in
the unfolded state, whereas the cysteines at positions 5 and 55 as well
as at 30 and 51 are farther apart from each other. The mutants of BPTI
were also labeled with the cysteine-specific label IOPI and
characterized by ESR. No effects due to dipolar interactions between
radicals bound to the protein in close vicinity can be observed even in
frozen solution (Fig. 4, C and D and Table II).
The fact that excimer formation is visible for positions 14 and 38 but
no dipolar interactions are observed in the corresponding ESR spectra
may be explained by a rather small population of cysteines that are in
close proximity. These may not be picked up in the ESR but are visible
in the more sensitive fluorescence measurements. Alternatively,
stacking of the aromatic pyrene residues may result in a small gain of
energy that allows for a local folding minimum, which will not be
formed when spin-labels are present instead. The addition of SecB to the unfolded, differently labeled BPTI mutants resulted in either a
decrease or the total loss of excimer fluorescence, indicative of a
conformational change within BPTI upon binding to the chaperone (Fig.
1, A through C, dotted lines).
Excitation spectra were recorded to investigate whether ground state
interactions occurred between the pyrenyl probes of the various labeled
single disulfide mutants of BPTI. The excitation spectra were recorded
from 280 to 360 nm for all the pyrene-labeled mutants in the presence
and absence of SecB, and pyrene emission was monitored at 377 and 470 nm (25, 39). The two excitation spectra differ, and the peaks of the spectra detected at 470 nm are red-shifted, decreased in intensity, and
broadened as compared with the peaks of the spectra detected at 377 nm,
indicating that the pyrene moieties that show excimers had already
formed dimers before excitation. In all the labeled BPTI mutants in the
free and bound state, there is a red shift observed in the excitation
spectra (data not shown). Also, the ratio of the fluorescence intensity
(F480 nm/F380 nm) was
found to vary with excitation wavelength, increasing slightly to the blue and sharply to the red of the minimum at 340 nm, in the free as
well as the bound state (data not shown). This wavelength dependence of
the fluorescence emission spectra as well as the broad red-shifted excitation spectra indicates a heterogeneous ground state environment for the pyrene chromophore in the labeled BPTI mutants even when bound
to SecB. An increase in fluorescence intensity was observed in all
pyrene-labeled mutants upon binding to SecB, and all labeled mutants
showed identical apparent binding affinities for SecB (Kd = 10 nM). All of the above is
consistent with SecB binding to multiple regions on the target
substrate rather than at a single site. Furthermore, the loss of
excimer fluorescence upon binding to SecB is consistent with an
extended conformation of the bound substrate protein.
Additional peaks in the high and low field area of the corresponding
ESR spectra of the three different spin-labeled BPTI mutants clearly
indicate that binding of the substrate proteins to SecB has taken place
(Fig. 4). The relatively high 2Azz value of 63 G is
suggestive of a rather immobilized radical component that arises
through binding of spin-labeled BPTI to a macromolecule like SecB. The
fact that a second spectral component similar to the rather sharp
signals of the unbound spin-labeled BPTI is present in the spectra and
that the fraction of spins in the rigid environment are approximately
equal to the mobile spins suggests that one of the spin labels on the
modified BPTI is in direct contact with SecB, whereas the second one
retains its mobility. This may be due to a rather extended form of the
bound BPTI where the more mobile radical reaches further away from the
surface of the chaperone. The d1/d
values observed in the frozen state (Table II) of less than 0.4 are
also consistent with an extended conformation of the bound substrate
where no dipolar interactions can be observed. The ESR spectra both for
the free and for the bound substrate are similar for all three mutants.
Consistent with the fluorescence data, these observations indicate that
SecB binds to multiple regions on the target substrate rather than at a
single site. The smallest separation between the two labeled Cys
residues is 21 residues in the 30-51 mutant. Since only one of the two
residues is immobilized upon binding, the binding site on each SecB
monomer of the tetramer must accommodate less than 21 residues.
Isothermal titration calorimetric experiments used to study the
interaction of unfolded BPTI with SecB also indicate that each SecB
monomer can bind 10-30 residues in a solvent-exposed rigid cleft (9). Interestingly, when a sequence as short as 10 residues (of which three
are basic) was inserted into alkaline phosphatase, this caused the
translocation of alkaline phosphatase to become dependent on SecB
in vivo (43). In addition, a recent study of SecB binding to
peptide fragments from a number of proteins suggested that the binding
site may be as short as nine residues (44) and that binding can occur
at multiple sites on a substrate protein. A similar ESR study carried
out using the B chain of insulin, a 26-residue peptide, also suggested
that the binding frame of SecB is around 10 residues (39). This is
entirely in agreement with results from the present study. In the
recently determined crystal structure of SecB (36), a deep groove lined
with aromatic amino acids (Subsite 1) was shown to have a length
sufficient to accommodate a polypeptide stretch of 10 amino acids.
Conformational Transition of SecB upon Binding Substrate
Protein--
To investigate potential conformational changes within
the structure of the chaperone SecB, we labeled the four
solvent-accessible cysteine residues of the chaperone either with
pyrene maleimide or with IOPI spin label. The presence of a single
pyrene was confirmed by ESI-MS of the labeled protein. MALDI mass
spectrometry analysis of the trypsin/CNBr cleavage of the
pyrene-labeled SecB along with the depth and accessibility analysis
showed that cysteine 97 is the most probable site of labeling.
No pyrene excimer formation was observed, suggesting that the
corresponding modified cysteines are too far apart from each other to
interact, in agreement with the modeled structure of SecB. However,
upon addition of unfolded (BPTI)all Ala, the fluorescence
of the dye increases, indicating that a conformational change may have occurred.
ESR spectroscopy using SecB that was modified with an IOPI spin-label
confirmed a conformational change within SecB upon binding of substrate
(BPTI). ESR spectra of frozen solutions of the modified proteins where
the radicals retain very low motional freedom exhibit a line-broadening
of the signals that most likely results from dipolar interaction of at
least two of the spin-labeled cysteines. The
d1/d ratio of 0.45 indicates a
distance of the radicals of less than 20 Å (22). Line shape
simulations as described in Steinhoff et al. (42) suggest
that the distance between the radicals is 14 ± 4.5 Å. The data
correlate very well with results from molecular modeling, where we
calculated the inter-spin distances of IOPI spin-labels in the
positions of cysteine 97 of the aligned structure for E. coli SecB. The structural model indicates a distance of 18 Å between the nitroxide radicals, which is within the 14 ± 4.5 Å distance determined by ESR, and computer simulation of the spectra.
Upon the addition of substrate protein, the
d1/d ratio decreased dramatically to
0.36, whereas the 2Azz value remained identical, indicating
that the radical moieties have moved apart from each other upon
substrate binding. The distance between the radicals is then too large
for dipolar interactions to occur. This is the first direct
demonstration of a conformational change within SecB upon binding of a
substrate protein.
 |
ACKNOWLEDGEMENTS |
We thank B. de Kruijff for kindly providing
the SecB expression plasmid pJW25 and P. S. Kim and Mike Millholen
for BPTI mutant plasmids. We thank M. K. Mathew for helpful
discussions and G. Kraft, M. Kersten, and P. Guhr for help in recording
spectra. We appreciate the help of H.-J. Steinhoff for providing the
program Dipfit for simulating the ESR spectra.
 |
FOOTNOTES |
*
This work was supported by grants from Department of Science
and Technology and Department of Biotechnology (to R. V.), by Bundesministerium für Bildung und Forschung Grant
INI-257-95, and by Fonds der Chemischen Industrie (to W. E. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a Journal of Cell Science Fellowship from the Company
of Biologists, United Kingdom and the Wood-Whelan Research Fellowship,
International Union of Biochemistry and Molecular Biology.
**
Recipient of the Swarnajayanthi Fellowship, Government of India and
a Senior Research Fellow of the Wellcome Trust. To whom correspondence should be addressed. Fax: 91-80-3600535 or
3600683; E-mail: varadar@mbu.iisc.ernet.in.
Published, JBC Papers in Press, July 2, 2001, DOI 10.1074/jbc.M104466200
 |
ABBREVIATIONS |
The abbreviations used are:
BPTI, bovine
pancreatic trypsin inhibitor;
(X-Y), BPTI
that has free thiols at positions X and Y, where
X and Y are 5-55 or 14-38 or 30-51;
(X-Y)Py, BPTI labeled at positions
X and Y with pyrene maleimide;
(X-Y)SL, BPTI labeled at positions
X and Y with a spin label (SL);
(BPTI)all Ala, completely unfolded BPTI, with alanine
residues substituted for all normally occurring cysteines;
IOPI, 4-(3-iodo-2-oxypropylidene-1-)-2,2,3,5,5-pentamethyl-imidazolidine-1-oxyl;
ESR, electron spin resonance;
MALDI, matrix-assisted laser desorption
ionization;
MS, mass spectroscopy.
 |
REFERENCES |
| 1.
|
Hartl, F. U.
(1996)
Nature
381,
571-580
|
| 2.
|
Gething, M.,
and Sambrook, J.
(1992)
Nature
355,
33-44
|
| 3.
|
Weiss, J. B.,
and Bassford, P. J.
(1990)
J. Bacteriol.
172,
3023-3029
|
| 4.
|
Lecker, S. H.,
Driessen, J. M.,
and Wickner, W.
(1990)
EMBO J.
9,
2309-2314
|
| 5.
|
Fekkes, P.,
Blaauwen, T.,
and Driessen, A. J. M.
(1995)
Biochemistry
34,
10078-10085
|
| 6.
|
Panse, V. G.,
Udgaonkar, J. B.,
and Varadarajan, R.
(1998)
Biochemistry
37,
14477-14483
|
| 7.
|
Hardy, S. J.,
and Randall, L. L.
(1991)
Science
251,
439-443
|
| 8.
|
Bychkova, V.,
Krummeck, G.,
and Ptitsyn, O. B.
(1988)
FEBS Lett.
238,
231-234
|
| 9.
|
Panse, V. G.,
Swaminathan, C. P.,
Surolia, A.,
and Varadarajan, R.
(2000)
Biochemistry
39,
2420-2427
|
| 10.
|
Staley, J. P.,
and Kim, P. S.
(1994)
Protein Sci.
3,
1822-1832
|
| 11.
|
Darby, N. J.,
Morin, P. E.,
Talbo, G.,
and Creighton, T. E.
(1995)
J. Mol. Biol.
249,
463-477
|
| 12.
|
Dadlez, M.,
and Kim, P. S.
(1996)
Biochemistry
35,
16153-16164
|
| 13.
|
Schulman, B. A.,
and Kim, P. S.
(1994)
Protein Sci.
3,
2226-2232
|
| 14.
|
Amir, D.,
and Haas, E.
(1988)
Biochemistry
27,
8889-8893
|
| 15.
|
Amir, D.,
Krausz, S.,
and Haas, E.
(1992)
Proteins
13,
162-173
|
| 16.
|
Gottfried, D. S.,
and Haas, E.
(1992)
Biochemistry
31,
12353-12362
|
| 17.
|
Gussakovsky, E. E.,
and Haas, E.
(1992)
FEBS Lett.
308,
146-148
|
| 18.
|
Pan, H.,
Barbar, E.,
Barnay, G.,
and Woodward, C.
(1995)
Biochemistry
34,
13974-13981
|
| 19.
|
Ferrer, M.,
Barany, G.,
and Woodward, C.
(1995)
Nat. Struct. Biol.
2,
211-217
|
| 20.
|
Lumb, K. J.,
and Kim, P. S.
(1994)
J. Mol. Biol.
236,
412-420
|
| 21.
|
Hubbell, W. L.,
Gross, A.,
Langen, R.,
and Lietzow, M. A.
(1998)
Curr. Opin. Struct. Biol.
8,
649-656
|
| 22.
|
Rabenstein, M. D.,
and Shin, Y. K.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8239-8243
|
| 23.
|
Farrens, D. L.,
Altenbach, C.,
Yang, K.,
Hubbell, W. L.,
and Khorana, H. G.
(1996)
Science
274,
768-770
|
| 24.
|
Altenbach, C.,
Yang, K.,
Farrens, D. L.,
Farahbakhsh, Z. T.,
Khorana, H. G.,
and Hubbell, W. L.
(1996)
Biochemistry
35,
12470-12478
|
| 25.
|
Lehrer, S. S.
(1997)
Methods Enzymol.
278,
286-295
|
| 26.
|
Zhao, M.,
Zen, K. C.,
Hubbell, W. L.,
and Kaback, H. R.
(1999)
Biochemistry
38,
7407-7412
|
| 27.
|
Sun, J.,
Voss, J.,
Hubbell, W. L.,
and Kaback, H. R.
(1999)
Biochemistry
38,
3100-3115
|
| 28.
|
Laemmli, U. K.
(1970)
Nature
277,
680-685
|
| 29.
|
Fasman, G. D.,
Park, K.,
and Randall, L.
(1995)
J. Protein Chem.
14,
595-600
|
| 30.
|
Staley, J. P.,
and Kim, P. S.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1519-1523
|
| 31.
|
Volodarsky, L. B.
(1988)
Imidazoline Nitroxides
, Vol. 1
, CRC Press, Inc., Boca Raton, FL
|
| 32.
|
Creighton, T. E.
(1990)
Protein Structure: A Practical Approach
, pp. 155-166, IRL Press at Oxford University Press, Oxford
|
| 33.
|
Panse, V. G.,
Swaminathan, C. P.,
Aloor, J. J.,
Surolia, A.,
and Varadarajan, R.
(2000)
Biochemistry
39,
2362-2369
|
| 34.
|
Darbre, A.
(ed)
(1986)
Practical Protein Chemistry: A Handbook
, Wiley Interscience, Chichester, Great Britain
|
| 35.
|
Sali, A.,
and Blundell, T. L.
(1993)
J. Mol. Biol.
234,
779-815
|
| 36.
|
Xu, Z.,
Knafles, J. D.,
and Yoshino, K.
(2000)
Nat. Struct. Biol.
7,
1172-1177
|
| 37.
|
Chakravarty, S.,
and Varadarajan, R.
(1999)
Structure (Lond.)
7,
723-732
|
| 38.
|
Lee, B.,
and Richards, F. M.
(1971)
J. Mol. Biol.
55,
379-400
|
| 39.
|
Panse, V. G.,
Vogel, P.,
Trommer, W. E.,
and Varadarajan, R.
(2000)
J. Biol. Chem.
275,
18698-18703
|
| 40.
|
Topping, T. B.,
Woodbury, R. L.,
Diamond, D. L.,
Hardy, S. J.,
and Randall, L. L.
(2001)
J. Biol. Chem.
276,
7437-7441
|
| 41.
|
Wenzel, H. R.,
Pfleiderer, G.,
Trommer, W. E.,
Paschenda, K.,
and Redhardt, A.
(1976)
Biochim. Biophys. Acta
452,
292-301
|
| 42.
|
Steinhoff, H.-J,
Radzwill, N.,
Thevis, W.,
Lenz, V.,
Brandenburg, D.,
Antson, A.,
Dodson, G.,
and Wollmer, A.
(1997)
Biophys. J.
73,
3287-3298
|
| 43.
|
Kim, J.,
and Kendall, D. A.
(1998)
J. Bacteriol.
180,
1396-1401
|
| 44.
|
Knoblauch, N. T.,
Rudiger, S.,
Schonfeld, H. J.,
Driessen, A. J.,
Schneider-Mergener, J.,
and Bukau, B.
(1999)
J. Biol. Chem.
274,
34219-34225
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Motz, T. Hornung, M. Kersten, D. T. McLachlin, S. D. Dunn, J. G. Wise, and P. D. Vogel
The Subunit b Dimer of the FoF1-ATP Synthase: INTERACTION WITH F1-ATPase AS DEDUCED BY SITE-SPECIFIC SPIN-LABELING
J. Biol. Chem.,
November 19, 2004;
279(47):
49074 - 49081.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|